| ［1］ |
Tasanen K, Tunggal L, Chometon G, et al. Keratinocytes from patients lacking collagen XVII display a migratory phenotype［J］. Am J Pathol, 2004,164（6）:2027⁃2038. doi: 10.1016/S0002⁃9440（10）63762⁃5.
|
| ［2］ |
Natsuga K, Watanabe M, Nishie W, et al. Life before and beyond blistering: the role of collagen XVII in epidermal physiology［J/OL］. Exp Dermatol, 2018.［2018⁃04⁃10］. https://onlinelibrary.wiley.com/doi/abs/10.1111/exd.13550. doi: 10.1111/exd.13550. ［published online ahead of print Mar 31, 2018］.
|
| ［3］ |
Powell AM, Sakuma⁃Oyama Y, Oyama N, et al. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex［J］. Clin Exp Dermatol, 2005,30（6）:682⁃687. doi: 10.1111/j.1365⁃2230.2005.01937.x.
|
| ［4］ |
Zillikens D. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes［J］. Keio J Med, 2002,51（1）:21⁃28.
|
| ［5］ |
Amber KT, Murrell DF, Schmidt E, et al. Autoimmune subepi⁃dermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management［J］. Clin Rev Allergy Immunol, 2018,54（1）:26⁃51. doi: 10.1007/s12016⁃017⁃8633⁃4. doi: 10.1007/ s12016⁃017⁃8633⁃4.
|
| ［6］ |
Lamberts A, Meijer JM, Jonkman MF. Nonbullous pemphigoid: a systematic review［J］. J Am Acad Dermatol, 2018,78（5）:989⁃995. doi: 10.1016/j.jaad.2017.10.035.
|
| ［7］ |
Cozzani E, Gasparini G, Burlando M, et al. Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects［J］. Autoimmun Rev, 2015,14（5）:438⁃445. doi: 10.1016/j.autrev. 2015.01.006.
|
| ［8］ |
李锁, 李志量, 荆可, 等. 盐裂皮肤间接免疫荧光及BP180NC16a酶联免疫吸附测定在大疱性类天疱疮诊断中的意义［J］. 中华皮肤科杂志, 2018,51（1）:10⁃13. doi: 10.3760/cma.j.issn.0412⁃4030.2018.01.003.
|
| ［9］ |
Zillikens D, Rose PA, Balding SD, et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies［J］. J Invest Dermatol, 1997,109（4）:573⁃579.
|
| ［10］ |
Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid［J］. Annu Rev Pathol, 2016,11:175⁃197. doi: 10.1146/annurev⁃pathol⁃012615⁃044313.
|
| ［11］ |
Lin L, Hwang BJ, Culton DA, et al. Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid［J］. J Invest Dermatol, 2018,138（5）:1032⁃1043. doi: 10.1016/j.jid.2017. 11.031.
|
| ［12］ |
Hofmann S, Thoma⁃Uszynski S, Hunziker T, et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2⁃ and COOH⁃terminal regions of the BP180 ectodomain［J］. J Invest Dermatol, 2002,119（5）:1065⁃1073. doi: 10.1046/j.1523⁃1747.2002.19529.x.
|
| ［13］ |
Zhao CY, Murrell DF. Advances in understanding and managing bullous pemphigoid［J］. F1000Res, 2015,4. pii: F1000 Faculty Rev⁃1313. doi: 10.12688/f1000research.6896.1.
|
| ［14］ |
Kamaguchi M, Iwata H, Ujiie H, et al. High of collagen XVII compensates for its depletion induced by pemphigoid IgG in the oral mucosa［J］. J Invest Dermatol, 2018,138（8）:1707⁃1715. doi: 10.1016/j.jid.2018.03.002.
|
| ［15］ |
Izumi K, Nishie W, Mai Y, et al. Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid［J］. J Invest Dermatol, 2016,136（11）:2201⁃2210. doi: 10.1016/j.jid.2016.06.622.
|
| ［16］ |
Chijiwa C, Takeoka S, Kamata M, et al. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase⁃4 inhibitor⁃related bullous pemphigoid［J］. J Dermatol, 2018,45（5）:596⁃599. doi: 10.1111/1346⁃8138.14245.
|
| ［17］ |
Schmidt E, Spindler V, Eming R, et al. Meeting report of the pathogenesis of pemphigus and pemphigoid meeting in munich, september 2016［J］. J Invest Dermatol, 2017,137（6）:1199⁃1203. doi: 10.1016/j.jid.2017.01.028.
|
| ［18］ |
Nader MA. Inhibition of airway inflammation and remodeling by sitagliptin in murine chronic asthma［J］. Int Immunopharmacol, 2015,29（2）:761⁃769. doi: 10.1016/j.intimp.2015.08.043.
|
| ［19］ |
Onprasert W, Chanprapaph K. Lichen planus pemphigoides induced by enalapril: a case report and a review of literature［J］. Case Rep Dermatol, 2017,9（3）:217⁃224. doi: 10.1159/000481449.
|
| ［20］ |
Warshafsky C, Tron VA, Robertson D, et al. Pemphigoid gestationis: a case presentation［J］. J Cutan Med Surg, 2018,22（4）:435⁃438. doi: 10.1177/1203475418760459.
|
| ［21］ |
Al Saif F, Jouen F, Hebert V, et al. Sensitivity and specificity of BP180 NC16A enzyme⁃linked immunosorbent assay for the diagnosis of pemphigoid gestationis［J］. J Am Acad Dermatol, 2017,76（3）:560⁃562. doi: 10.1016/j.jaad.2016.09.030.
|
| ［22］ |
Kanwar AJ. Pemphigoid gestationis［J］. Br J Dermatol, 2015,172（1）:6⁃7. doi: 10.1111/bjd.13457.
|
| ［23］ |
张江安, 于建斌. 妊娠类天疱疮的研究进展［J］. 中国医学文摘（皮肤科学）, 2016,33（5）:609⁃613.
|
| ［24］ |
Toyonaga E, Nishie W, Izumi K, et al. C⁃terminal processing of collagen XVII induces neoepitopes for linear IgA dermatosis autoantibodies［J］. J Invest Dermatol, 2017,137（12）:2552⁃2559. doi: 10.1016/j.jid.2017.07.831.
|
| ［25］ |
Fernandes KA, Galvis KH, Gomes AC, et al. Linear IgA and IgG bullous dermatosis［J］. An Bras Dermatol, 2016,91（5 suppl 1）:32⁃34. doi: 10.1590/abd1806⁃4841.20164630.
|
| ［26］ |
Yamauchi T, Matsushita S, Hashimoto T, et al. Major cleavage⁃dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non⁃collagenous 16A and collagenous 15 domains of BP180［J］. J Dermatol Sci, 2014,76（1）:25⁃33. doi: 10.1016/j.jdermsci.2014.07.008.
|
| ［27］ |
Kromminga A, Scheckenbach C, Georgi M, et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180［J］. J Autoimmun, 2000,15（3）:293⁃300. doi: 10.1006/jaut.2000.0437.
|
| ［28］ |
Pas HH, Kloosterhuis GJ, Heeres K, et al. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120⁃kDa keratinocyte collagenous glycoprotein with antigenic cross⁃reactivity to BP180［J］. J Invest Dermatol, 1997,108（4）:423⁃429.
|
| ［29］ |
Ohata C, Ishii N, Koga H, et al. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence［J］. Br J Dermatol, 2017,177（1）:152⁃157. doi: 10.1111/bjd.15232.
|
| ［30］ |
Yasukochi A, Teye K, Ishii N, et al. Clinical and immunological studies of 332 Japanese patients tentatively diagnosed as anti⁃BP180⁃type nucous nembrane pemphigoid: a Novel BP180 C⁃terminal domain enzyme⁃linked immunosorbent assay［J］. Acta Derm Venereol, 2016,96（6）:762⁃767. doi: 10.2340/00015555⁃2407.
|
| ［31］ |
Murrell DF, Marinovic B, Caux F, Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts［J］. J Am Acad Dermatol, 2015,72（1）:168⁃174. doi: 10.1016/j.jaad.2014.08.024.
|
| ［32］ |
Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators［J］. Arch Dermatol, 2002,138（3）:370⁃379.
|
